No black box warning on record for Hydroxyprogesterone Caproate

As of the latest FDA labeling reviewed, Hydroxyprogesterone Caproate (HYDROXYPROGESTERONE CAPROATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Hydroxyprogesterone Caproate medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Thrombotic and Thromboembolic Events Discontinue the medication pending examination if there is a sudden partial or complete loss of vision or if there is a sudden onset of proptosis, diplopia, or migraine. Medication should be stopped if examination reveals papilledema or retinal vascular lesions. Allergic reactions Hypersensitivity reaction to progestins have been reported. Hydroxyproge

No black box warning on record for Hydroxyprogesterone Caproate

Other warnings & precautions

WARNINGS Thrombotic and Thromboembolic Events Discontinue the medication pending examination if there is a sudden partial or complete loss of vision or if there is a sudden onset of proptosis, diplopia, or migraine. Medication should be stopped if examination reveals papilledema or retinal vascular lesions. Allergic reactions Hypersensitivity reaction to progestins have been reported. Hydroxyproge

Hydroxyprogesterone Caproate Black Box Warning

No black box warning on record for Hydroxyprogesterone Caproate

Other warnings & precautions

Hydroxyprogesterone Caproate Black Box Warning

No black box warning on record for Hydroxyprogesterone Caproate

Other warnings & precautions